TSLA Tesla Motors, Inc. gains 18% Dec 31, 2019

Tesla, Inc. designs, develops, manufactures, and sells electric vehicles and energy storage products in the United States, China, Norway, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. It primarily offers sedans and sport utility vehicles. The company also provides electric vehicle powertrain components and systems to other manufacturers; and services for electric vehicles through its 135 company-owned service centers and Service Plus locations, as well as through Tesla Ranger mobile technicians. It sells its products through a network of company-owned stores and galleries, as well as through Internet. In addition, the company offers energy storage products, such as rechargeable lithium-ion battery systems for use in homes, commercial facilities, and utility sites. Further, the company designs, manufactures, installs, maintains, leases, and sells solar energy systems to residential and commercial customers through a sales organization that include specialized internal call centers, outside sales force, a channel partner network, and a customer referral program, as well as through selected Tesla stores. Additionally, it sells renewable electricity generated by solar energy systems to customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was founded in 2003 and is headquartered in Palo Alto, California.http://www.priceseries.com/trade/TSLA-Tesla-Motors-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019120920191231.html

TGA Transglobe Energy Corp gains 17% Dec 31, 2019

TransGlobe Energy Corporation, through its subsidiaries, explores for, develops, and produces crude oil and natural gas liquids in Egypt and Canada. It holds working interests in West Gharib, West Bakr, North West Gharib, South West Gharib, South East Gharib, South Ghazalat, South Alamein, and North West Sitra production sharing contracts. TransGlobe Energy Corporation was founded in 1968 and is headquartered in Calgary, Canada.http://www.priceseries.com/trade/TGA-Transglobe-Energy-Corp-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2019121020191231.html

SOI Solaris Oilfield Infrastructure, Inc. gains 23% Dec 31, 2019

N/Ahttp://www.priceseries.com/trade/SOI-Solaris-Oilfield-Infrastructure-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2019120420191231.html

OSG Overseas Shipholding Group, Inc. gains 25% Dec 31, 2019

Overseas Shipholding Group, Inc. primarily engages in the ocean transportation of crude oil and petroleum products. As of December 31, 2015, the company owned or operated a fleet of 79 vessels aggregating 7.4 million deadweight tons and 864,800 cu...http://www.priceseries.com/trade/OSG-Overseas-Shipholding-Group-Inc-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2019121320191231.html

IBN ICICI Bank Ltd. gains 24% Dec 31, 2019

ICICI Bank Limited, together with its subsidiaries, provides banking and financial services in India and internationally. It operates through Retail Banking, Wholesale Banking, Treasury, Other Banking, Life Insurance, General Insurance, and Others segments. The company offers savings, salary, pension, current, other accounts; and fixed, recurring, fixed, and security deposits. It also provides home, car, personal, gold, and commercial business loans, as well as loans against securities and other loans; business loans, such as cash credit/overdrafts for working capital requirement, export credit, term loans, letters of credit, and bank guarantees; and credit, debit, prepaid, travel, and corporate cards. In addition, the company offers life, health, travel, car, two wheeler, home, and student medical insurance products; card protection plans; fire, marine, industrial, corporate, liability, and shop insurance products; pockets wallet; fixed income products; investment products, such as mutual funds, gold monetization schemes, and initial public offerings, as well as other online investment services; and farmer finance, tractor loans, and micro banking services, as well as other services to agri traders and processors, and agri corporates. Further, it provides portfolio management, trade, foreign exchange, locker, private and NRI banking, and cash management services; family wealth and demat accounts; commercial banking, investment banking capital markets and custodial, project and technology finance, and institutional banking services, as well as Internet, mobile, and phone banking services. Additionally, the company offers securities investment, broking, trading, and underwriting services; and merchant banking, private equity/venture capital fund management, trusteeship, and pension fund management services. As of March 31, 2016, it had a network of 4,450 branches and 13,766 ATM's. ICICI Bank Limited was founded in 1955 and is based in Mumbai, India.http://www.priceseries.com/trade/IBN-ICICI-Bank-Ltd-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019101520191231.html

EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) gains 18% Dec 31, 2019

Empresa Distribuidora y Comercializadora Norte Sociedad Anonima, a public service company, engages in the distribution and sale of electricity in Argentina. The company was formerly known as Empresa Distribuidora Norte Sociedad Anonima and changed its name to Empresa Distribuidora y Comercializadora Norte Sociedad Anonima in June 1996. The company was founded in 1992 and is based in Buenos Aires, Argentina. Empresa Distribuidora y Comercializadora Norte Sociedad Anonima is a subsidiary of Electricidad Argentina S.A.http://www.priceseries.com/trade/EDN-Empresa-Distribuidora-Y-Comercializadora-Norte-SA-Edenor-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019121320191231.html

CVEO Civeo Corp. gains 35% Dec 31, 2019

Civeo Corporation offers workforce accommodation, logistics, and facility management services to the natural resource industry in Canada, Australia, the United States, and internationally. The company develops lodges and villages, open camps, and mobile assets, including modular, skid-mounted accommodation, and central facilities that provide long-term and temporary work force accommodations. It also offers catering and food, housekeeping, recreation facility, laundry and facility management, water and wastewater treatment, power generation, communications, and personnel logistics services, as well as camp management services, including fresh water and sewage hauling services. The company operates 19 lodges and villages with approximately 24,000 rooms in Canada and Australia; 8 smaller open camp properties; and a fleet of mobile accommodation assets. It serves independent oil and natural gas, mining, and oilfield and mining service companies. The company is headquartered in Houston, Texas.http://www.priceseries.com/trade/CVEO-Civeo-Corp-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2019121120191231.html

CDXC Chromadex Corp gains 18% Dec 31, 2019

ChromaDex Corporation, a natural products company, discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies. The company offers bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; Nicotinamide riboside (NIAGEN), a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene (pTeroPure), a polyphenol and antioxidant used in health related fields; and Immulina, a spirulina extract and compound, which is used for improving human immune function, as well as developing Pterostilbene and caffeine co-crystal ingredients, and anthocyanins ingredients. It also provides reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. In addition, the company offers a range of contract services, including routine contract analysis for the production of dietary supplements, cosmetics, foods, and other natural products, as well as elaborate contract research for clients in these industries; and consulting services in the areas of regulatory support, new ingredient or product development, risk management, and litigation support, as well as product regulatory approval and scientific advisory services. Further, it assists customers in creating processes for manufacturing of natural products using green chemistry, as well as developing quality verification seal program, phytochemical libraries, plant extracts libraries, and databases for cross-referencing phytochemicals. The company markets and sells its products directly in the United States and Canada; and through distributors in Europe, China, Japan, South Korea, Brazil, Australia, New Zealand, Taiwan, South Africa, India, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation is based in Irvine, California.http://www.priceseries.com/trade/CDXC-Chromadex-Corp-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019120420191231.html

XOG Extraction Oil & Gas Inc gains 21% Dec 30, 2019

N/Ahttp://www.priceseries.com/trade/XOG-Extraction-Oil-&-Gas-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2019120520191230.html

TLYS Tillys, Inc. gains 18% Dec 30, 2019

Tilly's, Inc. retails casual apparel, footwear, and accessories for young men and women, and boys and girls in the United States. Its apparel merchandise includes tops, outerwear, bottoms, and dresses; and accessories merchandise comprises backpacks, hats, sunglasses, headphones, handbags, watches, jewelry, and others. The company also provides third-party merchandise assortment in its apparel, accessory, and footwear product categories. It operates approximately 222 stores in 31 states. The company also sells its products through its e-commerce Website, tillys.com. Tilly's, Inc. was founded in 1982 and is headquartered in Irvine, California.http://www.priceseries.com/trade/TLYS-Tillys-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019120420191230.html

THC Tenet Healthcare Corp. gains 65% Dec 30, 2019

Tenet Healthcare Corporation, together with its subsidiaries, operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including open-heart surgery, neonatal intensive care, and neurosciences; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, the company offers ambulatory surgery and urgent care centers, imaging centers, and short-stay surgical hospitals, as well as Aspen's hospitals and clinics; healthcare business process services in the areas of hospital and physician revenue cycle management and value-based care solutions; and microhospitals, physician practices, and health plans. Further, it provides accounts receivable and health information management, and revenue integrity and patient financial services; patient communications and engagement services; and clinical integration, financial risk management, and population health management services. As of February 27, 2017, the company operated 80 general acute care hospitals, 20 short-stay surgical hospitals, and approximately 470 outpatient centers, as well as 239 ambulatory surgery, 34 urgent care, and 21 imaging centers in the United States; and 9 private hospitals and clinics in the United Kingdom. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.http://www.priceseries.com/trade/THC-Tenet-Healthcare-Corp-stock-gains-65-percent-a-Trade-Record-by-priceSeries-2019101520191230.html

REI Ring Energy, Inc. gains 25% Dec 30, 2019

Ring Energy, Inc. acquires, explores for, develops, and produces oil and natural gas in Texas and Kansas, the United States. As of December 31, 2016, its proved reserves consisted of approximately 27.7 million barrel of oil equivalent. The company also owns interests in 32,663 net developed and undeveloped acres in Andrews and Gaines counties, and 20,490 net developed and undeveloped acres in Reeves and Culberson counties, Texas; and 14,549 net developed and undeveloped acres in Kansas. It primarily sells its oil and natural gas production to end users, marketers, and other purchasers. The company was formerly known as Transglobal Mining Corp. and changed its name to Ring Energy, Inc. in March 2008. Ring Energy, Inc. was founded in 2004 and is headquartered in Midland, Texas.http://www.priceseries.com/trade/REI-Ring-Energy-Inc-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2019120620191230.html

PDS Precision Drilling Corp. gains 25% Dec 30, 2019

Precision Drilling Corporation provides oil and natural gas drilling and related services and products. The company operates in two segments, Contract Drilling Services, and Completion and Production Services. The Contract Drilling Services segment offers onshore well drilling services to exploration and production companies in the oil and natural gas industry. This segment's services include land drilling, directional drilling, and turnkey drilling; and procurement and distribution of oilfield supplies, as well as manufacture and refurbishment of drilling and service rig equipment. As of December 31, 2016, this segment operated 255 land drilling rigs, including 135 in Canada; 103 in the United States; 5 in Mexico; 4 in Saudi Arabia; 5 in Kuwait; 2 in the Kurdistan region of Iraq; and 1 in the country of Georgia. The Completion and Production Services segment offers completion and workover services, and ancillary services to oil and natural gas exploration and production companies. It provides service rigs for well completion, workover, abandonment, maintenance, and re-entry preparation services; snubbing units for pressure control services; camp and catering services; and water system services. This segment also engages in the rental of oilfield surface equipment, and wellsite accommodations. This segment operated 196 well completion and workover service rigs, and 11 snubbing units in Canada and the United States; approximately 2,200 oilfield rental items, including surface storage, small-flow wastewater treatment, and power generation and solids control equipment; and 132 wellsite accommodation units in Canada. It also had 43 drilling camps and 4 base camps in Canada; and 10 large-flow wastewater treatment units, 24 pump houses, and 8 potable water production units in Canada. Precision Drilling Corporation was founded in 1951 and is headquartered in Calgary, Canada.http://www.priceseries.com/trade/PDS-Precision-Drilling-Corp-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2019120420191230.html

OVID Ovid Therapeutics, Inc. gains 74% Dec 30, 2019

N/Ahttp://www.priceseries.com/trade/OVID-Ovid-Therapeutics-Inc-stock-gains-74-percent-a-Trade-Record-by-priceSeries-2019111420191230.html

NBR Nabors Industries Ltd. gains 40% Dec 30, 2019

Nabors Industries Ltd. provides drilling and rig services. The company offers equipment manufacturing, rig instrumentation, optimization software, and directional drilling services; and It provides patented steering systems and rig instrumentation software systems, including ROCKIT directional drilling system that provides data collection services to oil and gas exploration and service companies; REVit control system, a stick slip mitigation system; RIGWATCH software, which monitors a rig's real-time performance and offers daily reporting for drilling operations; and DRILLSMART software that allows the drilling system to adapt to operating parameters and drilling conditions. The company also provides measurement while drilling systems and services; manufactures and sells top drives, catwalks, wrenches, draw works, and other drilling related equipment; and offers well-site services, such as engineering, transportation and disposal, construction, maintenance, well logging, directional drilling, data collection, and other support services. As of December 31, 2016, it marketed approximately 400 rigs for land-based drilling operations in the United States, Canada, and approximately 20 other countries worldwide; 41 rigs for offshore drilling operations in the United States and internationally. The company was founded in 1968 and is headquartered in Hamilton, Bermuda.http://www.priceseries.com/trade/NBR-Nabors-Industries-Ltd-stock-gains-40-percent-a-Trade-Record-by-priceSeries-2019120520191230.html

MRSN Mersana Therapeutics, Inc. gains 24% Dec 30, 2019

N/Ahttp://www.priceseries.com/trade/MRSN-Mersana-Therapeutics-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019121920191230.html

LE Lands End, Inc. gains 19% Dec 30, 2019

Lands' End, Inc. operates as a multi-channel retailer in the United States, the United Kingdom, Germany, and Japan. The company operates through two segments, Direct and Retail. It offers casual clothing, accessories, footwear, and home products. The company sells its products online through landsend.com, and affiliated specialty and international Websites; direct mail catalogs; and retail locations primarily at Lands' End Shops at Sears, Lands' End Inlet stores, and international shop-in-shops. As of January 27, 2017, it operated 216 Lands' End Shops at Sears; and 14 Lands' End Inlet stores. Lands' End, Inc. was founded in 1963 and is headquartered in Dodgeville, Wisconsin.http://www.priceseries.com/trade/LE-Lands-End-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2019120320191230.html

JKS JinkoSolar Holding Company Ltd. gains 17% Dec 30, 2019

JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products in the People's Republic of China and internationally. It offers solar modules, solar cells, silicon ingots, silicon wafers, and recovered silicon materials. The company sells its products to distributors, project developers, and system integrators under the JinkoSolar brand, as well as on an original equipment manufacturer basis. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.http://www.priceseries.com/trade/JKS-JinkoSolar-Holding-Company-Ltd-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2019120420191230.html

IMGN ImmunoGen, Inc. gains 30% Dec 30, 2019

ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.http://www.priceseries.com/trade/IMGN-ImmunoGen-Inc-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2019121620191230.html

IFRX InflaRx N.V. gains 16% Dec 30, 2019

http://www.priceseries.com/trade/IFRX-InflaRx-NV-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019121220191230.html

EYE National Vision Holdings, Inc. gains 16% Dec 30, 2019

N/Ahttp://www.priceseries.com/trade/EYE-National-Vision-Holdings-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019112020191230.html

ESTE Earthstone Energy, Inc. gains 17% Dec 30, 2019

Earthstone Energy, Inc., an oil and natural gas development and production company, operates in the up-stream segment of the oil and natural gas industry in the United States. Its asset portfolio includes the Midland Basin of west Texas, the Eagle Ford trend of south Texas, and in the Williston Basin of North Dakota. As of December 31, 2016, the company operated 70 gross Eagle Ford wells; and 9 gross Austin Chalk wells, as well as had 12,051 thousand barrels of oil equivalent (MBOE) of total proved reserves, 9,361 MBOE of proved developed reserves, and 2,690 MBOE of proved undeveloped reserves. Earthstone Energy, Inc. was founded in 1969 and is headquartered in The Woodlands, Texas.http://www.priceseries.com/trade/ESTE-Earthstone-Energy-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2019120620191230.html

EROS Eros Intl. PLC gains 20% Dec 30, 2019

Eros International PLC, together with its subsidiaries, co-produces, acquires, and distributes Indian language films in various formats worldwide. The company distributes its film content across various distribution channels, such as theatrical, which includes multiplex chains and stand-alone theaters; television syndication that comprises satellite television broadcasting, cable television, and terrestrial television; and digital and ancillary, which consist of music, inflight entertainment, home video, Internet protocol television, video on demand, and Internet channels, as well as on-demand entertainment portals through Internet-enabled devices. It also distributes its film content through physical formats, such as DVDs and video compact discs (VCDs) in hotels and on airlines, and for use on mobile networks; and distributes and licenses content on physical media, including on Blu-ray and DVDs internationally, as well as on VCDs and DVDs in India. In addition, the company distributes its film content to retail chains and Internet platforms, as well as to wholesalers and retailers; and licenses content to third party distributors internationally to provide content dubbed into local languages for non-South Asian audiences. Further, it is involved in direct sales to corporate customers who bundle the company's DVDs or VCDs with their products for promotional purposes. The company has rights for approximately 3,000 films in its library. Additionally, it operates as a music publisher for third party owned music rights. The company also provides music content directly, as well as through third party platforms and licensing deals; and through streaming services, digital streaming, CDs, and publishing/master rights licensing. Eros International PLC was founded in 1977 and is based in Secaucus, New Jersey.http://www.priceseries.com/trade/EROS-Eros-Intl-PLC-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2019120620191230.html

ENPH Enphase Energy, Inc. gains 32% Dec 30, 2019

Enphase Energy, Inc., together with its subsidiaries, designs, develops, and sells microinverter systems for residential and commercial markets in the United States and internationally. The company's semiconductor-based microinverter system converts direct current electricity to alternating current (AC) electricity at the individual solar module level. It also offers energy storage systems, including its AC battery; and energy monitoring and control services. The company sells its microinverter systems primarily to distributors, as well as directly to large installers through original equipment manufacturers and strategic partners. Enphase Energy, Inc. was founded in 2006 and is headquartered in Petaluma, California.http://www.priceseries.com/trade/ENPH-Enphase-Energy-Inc-stock-gains-32-percent-a-Trade-Record-by-priceSeries-2019112220191230.html

DBD Diebold, Incorporated gains 37% Dec 30, 2019

Diebold Nixdorf, Incorporated provides connected commerce services, software, and technology for financial, commercial, and industrial customers. The company operates in four segments: North America; Asia Pacific; Europe, Middle East and Africa; and Latin America. It offers financial self-service solutions and technologies, including automated teller machine (ATM) outsourcing, ATM security, deposit automation, recycling and payment terminals, and software. The company also provides financial self-service support and maintenance services comprising installation and ongoing maintenance of products, availability management, branch automation, and distribution channel consulting; outsourced and managed services, such as remote monitoring, troubleshooting, transaction processing, currency management, maintenance, and online communication services; and strategic analysis and planning for new systems, systems integration, architectural engineering, consulting, and project management services, as well as multi-vendor services. In addition, it offers electronic security services and products; security monitoring solutions comprising remote monitoring and diagnostics, fire detection, intrusion protection, managed access control, energy management, remote video management and storage, logical security, and Web-based solutions; and physical security and facility products. Further, the company provides development, training, support, and maintenance of elections and lottery equipment, networking, tabulation, and diagnostic software; and IT solutions and services to retail banks and the retail industry. The company was formerly known as Diebold, Incorporated and changed its name to Diebold Nixdorf, Incorporated in December 2016. Diebold Nixdorf, Incorporated was founded in 1859 and is headquartered in North Canton, Ohio.http://www.priceseries.com/trade/DBD-Diebold-Incorporated-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2019121120191230.html

CTMX CytomX Therapeutics, Inc. gains 32% Dec 30, 2019

Preclinical biotech developing tumor-activated cancer immunotherapies.http://www.priceseries.com/trade/CTMX-CytomX-Therapeutics-Inc-stock-gains-32-percent-a-Trade-Record-by-priceSeries-2019120620191230.html

CLMT Calumet Specialty Products Partners, L.P. gains 15% Dec 30, 2019

Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America. It operates in three segments: Specialty Products, Fuel Products, and Oilfield Services. The Specialty Products segment offers various lubricating oils, white mineral oils, petrolatums, solvents, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods. The Fuel Products segment provides fuel and fuel-related products, including gasoline, diesel, jet fuel, asphalt, and heavy fuel oils, as well as resells purchased crude oil to third party customers. The Oilfield Services segment manufactures and markets drilling fluids, completion fluids, and solids control services to the oil and gas exploration industry. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1916 and is headquartered in Indianapolis, Indiana.http://www.priceseries.com/trade/CLMT-Calumet-Specialty-Products-Partners-LP-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019120620191230.html

CLLS Cellectis S.A. gains 31% Dec 30, 2019

Developing cancer immunotherapies based on gene-edited CAR T-cells.http://www.priceseries.com/trade/CLLS-Cellectis-SA-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2019112120191230.html

AZZ AZZ Inc. gains 20% Dec 30, 2019

AZZ incorporated provides galvanizing services, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, and industrial markets. The company operates through two segments, Energy and Galvanizing Services. The Energy segment provides specialized products and services designed to support industrial, nuclear, and electrical applications. This segment offers custom switchgear, electrical enclosures, medium and high voltage bus ducts, explosion proof and hazardous duty lighting, nuclear safety-related equipment, and tubular products to multi-national companies, and small independent companies. It also supplies safety related equipment for the nuclear industry. This segment sells its products through manufacturers' representatives, distributors, agents, and internal sales force. The Galvanizing Services segment offers hot dip galvanizing services to the steel fabrication industry. This segment serves fabricators or manufacturers that provide services to the electrical and telecommunications, bridge and highway, petrochemical, and general industrial markets, as well as original equipment manufacturers. As of February 29, 2016, the company operated 43 galvanizing plants located in Alabama, Arkansas, Arizona, Colorado, Indiana, Illinois, Louisiana, Kentucky, Minnesota, Mississippi, Missouri, Nebraska, Nevada, Ohio, Oklahoma, Tennessee, Texas, Virginia, and West Virginia in the United States; and Ontario, Quebec, and Nova Scotia, Canada. AZZ incorporated was founded in 1956 and is based in Fort Worth, Texas.http://www.priceseries.com/trade/AZZ-AZZ-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2019120420191230.html

ASMB Assembly Biosciences, Inc. gains 46% Dec 30, 2019

Assembly Biosciences, Inc., a clinical stage biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics to restore health to a dysbiotic microbiome in the United States. It is involved in developing core protein allosteric modulators that modulate the HBV core protein at various points in the viral lifecycle. The company also develops microbiome program, a platform that includes the identification and selection process to strain isolation and growth under current good manufacturing practice conditions; and a patent pending delivery system, GEMICEL, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. Its lead product candidate from the platform is AB-M101 that has been completed Phase Ia clinical trial to treat clostridium difficile infections. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana.http://www.priceseries.com/trade/ASMB-Assembly-Biosciences-Inc-stock-gains-46-percent-a-Trade-Record-by-priceSeries-2019112220191230.html

AMAG AMAG Pharmaceuticals, Inc. gains 23% Dec 30, 2019

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, manufactures, develops, and commercializes therapeutics for women's health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units for pregnant women and their families. In addition, it has a option agreement with Velo to acquire the rights to digoxin immune fab, a polyclonal antibody in clinical development for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. It has a license agreement with Palatin Technologies, Inc. to research, develop, and commercialize Rekynda, an investigational product designed to be an on-demand treatment for hypoactive sexual desire disorder in pre-menopausal women, as well as with Endoceutics, Inc. to develop and commercialize pharmaceutical products with dehydroepiandrosterone; and development and license agreement with Antares Pharma, Inc. to develop, use, sell, and offer for sale and import and export the Makena auto-injector. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.http://www.priceseries.com/trade/AMAG-AMAG-Pharmaceuticals-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2019112020191230.html

AGIO Agios Pharmaceuticals, Inc. gains 41% Dec 30, 2019

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines for the treatment of cancer and rare genetic metabolic disorders in the United States. It is developing Enasidenib, a potent inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein that is in Phase 1/2 clinical trial for patients with advanced hematologic malignancies with an IDH 2 mutation; Phase 3 clinical trial for patients with IDH2 mutant-positive acute myeloid leukemia (AML); Phase 1b frontline combination trial for patients with newly diagnosed AML with an IDH2 or IDH1 mutation; and Phase 1/2 frontline combination trial for patients with newly diagnosed AML. The company is also developing Ivosidenib, a potent inhibitor of the mutated IDH1 protein, which is in Phase 1 clinical trial for patients with advanced hematologic malignancies with an IDH1 mutation; Phase 1 clinical trial for advanced solid tumors; Phase 3 clinical trial for patients with nonresectable or metastatic cholangiocarcinoma with an IDH1 mutation; Phase 1b frontline combination trial for patients with newly diagnosed AML with an IDH2 or IDH1 mutation; and Phase 1/2 frontline combination and Phase 3 clinical trials for newly diagnosed AML patients. In addition, it is developing AG-881, a pan-IDH mutant inhibitor that is in Phase 1 clinical trials for the treatment of hematologic malignancies and solid tumors; and AG-348, a small molecule potent activator that is in Phase 2 clinical trial for the treatment of pyruvate kinase deficiency. It has a collaboration and license agreement with Celgene Corporation to discover, develop, and commercialize disease-altering therapies in oncology; and Celgene International II Sarl to develop and commercialize AG-881 products. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/AGIO-Agios-Pharmaceuticals-Inc-stock-gains-41-percent-a-Trade-Record-by-priceSeries-2019111220191230.html

AERI Aerie Pharmaceuticals, Inc. gains 20% Dec 30, 2019

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its lead product candidate includes Rhopressa, a once-daily eye drop for the reduction of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. The company is also developing Roclatan, a once-daily eye drop to reduce IOP that is in Phase III registration trials to treat patients with open-angle glaucoma and ocular hypertension. Aerie Pharmaceuticals, Inc. was founded in 2005 and is based in Irvine, California.http://www.priceseries.com/trade/AERI-Aerie-Pharmaceuticals-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2019120320191230.html

ADAP Adaptimmune Therapeutics plc gains 44% Dec 30, 2019

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its proprietary SPEAR T-cell platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company's lead program includes NY-ESO-1 and LAGE-1a cancer antigens, which are in Phase I/II clinical trials for patients with solid tumors, as well as hematological cancer types, including synovial sarcoma, multiple myeloma, non-small cell lung cancer (NSCLC), and ovarian cancer; and pilot trial for myxoid round cell liposarcoma. It is also developing MAGE A-10 peptide that is in Phase I/II clinical trials to treat urothelial (bladder), melanoma, and head and neck cancers, as well as NSCLC; AFP SPEAR T-cell therapeutic candidate that has completed preclinical testing for targeting a peptide associated with hepatocellular carcinoma; and MAGE-A4 to treat urothelial (bladder), melanoma, head and neck, esophageal and gastric, and ovarian cancer, as well as NSCLC. It has a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialization of the NY-ESO SPEAR T-cell program; and strategic alliance with MD Anderson Cancer Center for the development of T-cell therapies for various cancers. The company also has a clinical trial collaboration agreement with Merck & Co., Inc. for the assessment of NY-ESO SPEAR T-cell in combination with anti-programmed death-1 inhibitor in patients with multiple myeloma; and a research, collaboration, and license agreement with Universal Cells, Inc. to gene editing and HLA-engineering technology, as well as a collaboration agreement with Bellicum Pharmaceutical Inc. to evaluate, develop, and commercialize next generation T-cell therapies. Adaptimmune Therapeutics plc was founded in 2014 and is headquartered in Abingdon, the United Kingdom.http://www.priceseries.com/trade/ADAP-Adaptimmune-Therapeutics-plc-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2019112520191230.html

ACRX AcelRx Pharmaceuticals, Inc. gains 16% Dec 30, 2019

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet, which is in Phase III clinical trial for the treatment of moderate-to-severe acute pain. The company's late-stage investigational product candidate is Zalviso, a pre-programmed and patient-controlled analgesia device that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. Zalviso is approved in the European Union, Switzerland, Liechtenstein, Iceland, Norway and Australia, or the Territory; and is under development stage in the United States. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.http://www.priceseries.com/trade/ACRX-AcelRx-Pharmaceuticals-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019120620191230.html

ACMR AMC Research, Inc. gains 24% Dec 30, 2019

http://www.priceseries.com/trade/ACMR-AMC-Research-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019120520191230.html

VAR Varian Medical Systems, Inc. gains 24% Dec 26, 2019

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation, verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, oncology practices, radiotherapy centers, and cancer care clinics. The Imaging Components segment offers X-ray imaging components for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer aided diagnostics, and industrial applications. It also provides Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes. This segment serves original equipment manufacturers, independent service companies, and end-users. In addition, the company offers products and systems for delivering proton therapy; and develops technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.http://www.priceseries.com/trade/VAR-Varian-Medical-Systems-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019101720191226.html

PFNX Pfenex Inc. gains 24% Dec 26, 2019

Pfenex Inc., a clinical-stage biotechnology company, develops biosimilar therapeutics in the United States. Its lead product candidates include PF708, a therapeutic equivalent candidate to Forteo (teriparatide) for the treatment of osteoporosis; PF582, a biosimilar to Lucentis (ranibizumab) for the treatment of patients with retinal diseases; and Px563L, a novel anthrax vaccine candidate in Phase 1a trial. The company also engages in developing a pipeline of additional biosimilar candidates, including PF529, a biosimilar candidate to Neulasta; PF688, a biosimilar candidate to Cimzia; PF530, a biosimilar candidate to Betaseron; PF690, a biosimilar candidate to the reference product Oncaspar; PF444-human growth hormone, a biosimilar candidate to Genotropin; and PF688-certolizumab-pegol, a biosimilar candidate to Cimzia. It has collaboration agreements with Hospira, Inc. and Jazz Pharmaceuticals Ireland Limited. Pfenex Inc. is headquartered in San Diego, California.http://www.priceseries.com/trade/PFNX-Pfenex-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2019112520191226.html

FORR Forrester Research, Inc. gains 20% Dec 26, 2019

Forrester Research, Inc. operates as an independent research, data, and advisory services company. It operates through Research, Product, and Project Consulting segments. The company's primary syndicated research product is RoleView, which offers clients with access to its syndicated research designed to inform their strategic decision-making. The RoleView research offerings consist of cross-linked documents that interconnect the company's playbooks, reports, data, product rankings, best practices, evaluation tools, and research archives, which are provided through role-based Websites. It also offers Leadership Boards that are peer groups for executives and other senior leaders at large organizations. In addition, the company provides data products and services, including Customer Experience Index, a framework for assessing and measuring customer experience quality; Consumer Technographics that offers insights into how technology impacts the way consumers select, purchase, use, and communicate about products and services; Business Technographics, which provides assessments of what motivates businesses to choose certain technologies and vendors, as well as measures and reports on the current information consumption patterns of key influencers for large technology purchases; and ForecastView, an ongoing data program that provides a detailed evaluation of market size, based on expert analysis and quantitative insights from consumer and business surveys. Further, it offers consulting services to assist clients in developing and executing technology and business strategy, informing critical decisions, and reducing business risk, as well as hosts various events. The company sells its products and services through direct sales force in North America, Europe, Asia, and Australia; and through independent sales representatives in selected locations internationally. Forrester Research, Inc. was founded in 1983 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/FORR-Forrester-Research-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2019110120191226.html

CEMI Chembio Diagnostics, Inc. gains 15% Dec 26, 2019

Chembio Diagnostics, Inc., together with its subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The company's products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV 1/2 Assay Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a DPP HIV-Syphilis multiplex test for the detection of antibodies to HIV and syphilis; and a test for the detection of Hepatitis-C. Chembio Diagnostics, Inc. sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with Concussion Science Group Division of Perseus Science Group LLC to develop a POC diagnostic test for traumatic brain injury; and collaboration with an international diagnostics company to develop a POC diagnostic test for a specific type of cancer. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.http://www.priceseries.com/trade/CEMI-Chembio-Diagnostics-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019120920191226.html

SBGL Sibanye Gold Ltd. gains 15% Dec 20, 2019

Sibanye Gold Limited owns and operates underground and surface gold operations in South Africa. The company holds interests in the Driefontein Operations covering an area of approximately 8,561 hectares; the Kloof Operations covering an area of approximately 20,100 hectares; and the Cooke Operations located in the West Witwatersrand region, as well as in the Beatrix Operations covering an area of approximately 16,821 hectares in the Free State province of South Africa. As of December 31, 2015, it had proved and probable gold reserves of approximately 30.988Moz; and probable uranium reserves of approximately 113.8Mlb. The company also owns and operates platinum mines in South Africa. Sibanye Gold Limited was incorporated in 2002 and is based in Westonaria, South Africa.http://www.priceseries.com/trade/SBGL-Sibanye-Gold-Ltd-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019112920191220.html

RYI Ryerson Holding Corp. gains 20% Dec 20, 2019

Ryerson Holding Corporation, together with its subsidiaries, processes and distributes industrial metals in the United States, Mexico, Canada, China, and Brazil. The company offers a line of stainless steel, aluminum, carbon steel, and alloy steels, as well as nickel and red metals in various shapes and forms, including coils, sheets, rounds, hexagons, square and flat bars, plates, structural products, and tubes. It also provides value-added processing and fabrication services ranging from sawing, slitting, blanking, cutting to length, leveling, flame cutting, laser cutting, edge trimming, edge rolling, roll forming, tube manufacturing, polishing, shearing, forming, stamping, punching, and rolling shell plate to radius and beveling; and processing materials. The company serves various industries, such as commercial ground transportation manufacturing, metal fabrication and machine shops, industrial machinery and equipment manufacturing, consumer durables production, HVAC manufacturing, construction equipment manufacturing, food processing and agriculture equipment manufacturing, and oil and gas. Ryerson Holding Corporation was founded in 1842 and is headquartered in Chicago, Illinois.http://www.priceseries.com/trade/RYI-Ryerson-Holding-Corp-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2019112520191220.html

IEC IEC Electronics Corp. gains 30% Dec 20, 2019

IEC Electronics Corp., together with its subsidiaries, provides electronic contract manufacturing services in the United States. It specializes in delivering technical solutions for the custom manufacturing, product configuration, and verification testing of complex products that require a sophisticated level of manufacturing. The company manufactures a range of assemblies that are incorporated into various products, such as aerospace and defense systems, medical devices, industrial equipment, and transportation products. It serves aerospace, medical, industrial, and defense sectors through a direct sales force, as well as through a network of manufacturer's representatives. The company was founded in 1966 and is headquartered in Newark, New York.http://www.priceseries.com/trade/IEC-IEC-Electronics-Corp-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2019110720191220.html

AKBA Akebia Therapeutics, Inc. gains 47% Dec 20, 2019

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product candidates that include AKB-6899 for the treatment of anemia; and AKB-5169, a preclinical compound for the treatment for inflammatory bowel disease. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, as well as with Mitsubishi Tanabe Pharma Corporation for the development and commercialization to vadadustat in Japan and other Asian countries. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/AKBA-Akebia-Therapeutics-Inc-stock-gains-47-percent-a-Trade-Record-by-priceSeries-2019112220191220.html

SNDX Syndax Pharmaceuticals, Inc. gains 15% Dec 18, 2019

Developing a therapy that enhances checkpoint immuno-oncology drugs.http://www.priceseries.com/trade/SNDX-Syndax-Pharmaceuticals-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019120420191218.html

GBT GLOBAL BLOOD THERAPEUTICS, INC. gains 52% Dec 18, 2019

Global Blood Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its lead product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in Phase 3 clinical trial for the treatment of sickle cell disease (SCD) in adult and adolescent patients, as well as evaluates the safety and pharmacokinetics of single and multiple doses of GBT440 on adolescent patients with SCD. The company is also involved in conducting Phase 2 clinical trials of GBT440 for the treatment of idiopathic pulmonary fibrosis, which is a hypoxemic pulmonary disorder; and other pre-clinical research and development activities. Global Blood Therapeutics Inc. was founded in 2011 and is headquartered in South San Francisco, California.http://www.priceseries.com/trade/GBT-GLOBAL-BLOOD-THERAPEUTICS-INC-stock-gains-52-percent-a-Trade-Record-by-priceSeries-2019111220191218.html

FGEN FibroGen, Inc gains 23% Dec 18, 2019

FibroGen, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs in the United States. It is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; Pamrevlumab, a human-monoclonal antibody that inhibits the activity of connective tissue growth factor, which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and Duchenne muscular dystrophy; and FG-5200 for the treatment of corneal blindness resulting from partial thickness corneal damage. It has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was incorporated in 1993 and is headquartered in San Francisco, California.http://www.priceseries.com/trade/FGEN-FibroGen-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2019111920191218.html

CTIC CTI BioPharma Corp. gains 21% Dec 18, 2019

CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also developing Pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R, which is in Phase Phase III clinical trials for the treatment of myelofibrosis. In addition, it is developing Tosedostat, an oral once-daily aminopeptidase inhibitor that is in Phase II clinical trials for the treatment of acute myeloid leukemia. The company has license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier; development, commercialization, and license agreement with Baxter International Inc.; agreement with the University of Vermont, BIO Pte Ltd., Gynecologic Oncology Group, and PG-TXL Company, L.P; and license agreement with Vernalis (R&D) Limited. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was founded in 1991 and is headquartered in Seattle, Washington.http://www.priceseries.com/trade/CTIC-CTI-BioPharma-Corp-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2019121020191218.html

CLRB Cellectar Biosciences, Inc. gains 32% Dec 18, 2019

Cellectar Biosciences, Inc., a clinical stage biopharmaceutical company, engages in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate and is currently being evaluated in a Phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was formerly known as Novelos Therapeutics, Inc. and changed its name to Cellectar Biosciences, Inc. in February 2014. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Madison, Wisconsin.http://www.priceseries.com/trade/CLRB-Cellectar-Biosciences-Inc-stock-gains-32-percent-a-Trade-Record-by-priceSeries-2019112220191218.html

PCG Pacific Gas & Electric Co. gains 36% Dec 16, 2019

PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California. The company's electricity distribution network consists of approximately 142,000 circuit miles of distribution lines, 59 transmission switching substations, and 606 distribution substations; and electricity transmission network comprises approximately 18,400 circuit miles of interconnected transmission lines and 92 electric transmission substations. Its natural gas system consists of approximately 42,800 miles of distribution pipelines, approximately 6,700 miles of backbone and local transmission pipelines, and various storage facilities. The company operates various electricity generation facilities, such as nuclear, hydroelectric, fossil fuel-fired, and photovoltaic. PG&E Corporation was founded in 1905 and is headquartered in San Francisco, California.http://www.priceseries.com/trade/PCG-Pacific-Gas-&-Electric-Co-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2019112920191216.html